Clinical trial
Irbesartan Versus Placebo in Combination With Ramipril for Treatment of…
NCT00095290 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00095290 |
|---|---|
| Title | Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria |
| Official title | Irbesartan Versus Placebo in Combination With Standard Cardiovascular Protection ACE-I Therapy With Ramipril for the Treatment of Albuminuria in Hypertensive Subjects at Elevated Cardiovascular Risk |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Collaborators | Sanofi Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Albuminuria |
| Intervention type | Drug |
| Interventions | Ramipril + Irbesartan, Ramipril + Placebo |
| Enrollment | 400 |
| Start date | Sep 1, 2004 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Nov 3, 2004 |
| Last update posted | Apr 15, 2011 |
| Countries | Australia, Canada, France, Germany, Israel, Italy, Latvia, Lithuania, Mexico, Netherlands, Russia, Spain and 2 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: